World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
101
Citations
34153
World Ranking
8042
National Ranking
4174

Overview

Beow Y. Yeap is affiliated with Harvard University in the United States and has a research focus primarily in Medicine, with significant contributions in the subfields of Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Genetics, and Molecular Biology.

The researcher's work spans several main topics including Lung Cancer Treatments and Mutations, Cancer Genomics and Diagnostics, Lung Cancer Research Studies, Pancreatic and Hepatic Oncology Research, Glioma Diagnosis and Treatment, Cancer Immunotherapy and Biomarkers, and Lung Cancer Diagnosis and Treatment.

The recent publications reflect these areas of study and include:

  • Radiation therapy enhances immunotherapy response in microsatellite stable colorectal and pancreatic adenocarcinoma in a phase II trial, 2021, Nature Cancer
  • MET Alterations Are a Recurring and Actionable Resistance Mechanism in ALK-Positive Lung Cancer, 2020, Clinical Cancer Research
  • Spectrum of Mechanisms of Resistance to Crizotinib and Lorlatinib in ROS1 Fusion-Positive Lung Cancer, 2021, Clinical Cancer Research
  • Therapy-induced APOBEC3A drives evolution of persistent cancer cells, 2023, Nature
  • Dosimetric Analysis and Normal-Tissue Complication Probability Modeling of Child-Pugh Score and Albumin-Bilirubin Grade Increase After Hepatic Irradiation, 2020, International Journal of Radiation Oncology*Biology*Physics

Frequent co-authors collaborating with Beow Y. Yeap include Theodore S. Hong, Justin F. Gainor, Jennifer Y. Wo, W. Marston Linehan, and Torunn I. Yock.

The researcher's publications appear mainly in the following venues:

  • Journal of Clinical Oncology
  • International Journal of Radiation Oncology*Biology*Physics
  • Journal of Thoracic Oncology
  • Neuro-Oncology
  • JTO Clinical and Research Reports

Best Publications

  • Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALK

    Alice T. Shaw;Beow Y. Yeap;Mari Mino-Kenudson;Subba R. Digumarthy

  • Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC

    Alexa B. Turke;Kreshnik Zejnullahu;Yi Long Wu;Youngchul Song

  • Effect of crizotinib on overall survival in patients with advanced non-small-cell lung cancer harbouring ALK gene rearrangement: a retrospective analysis.

    Alice T. Shaw;Beow Y. Yeap;Benjamin J. Solomon;Gregory J. Riely

  • EGFR Mutations and ALK Rearrangements Are Associated With Low Response Rates to PD-1 Pathway Blockade in Non-Small Cell Lung Cancer: A Retrospective Analysis

    Justin F. Gainor;Alice T. Shaw;Lecia V. Sequist;Xiujun Fu

  • Unique clinicopathologic features characterize ALK-rearranged lung adenocarcinoma in the western population.

    Scott J. Rodig;Mari Mino-Kenudson;Sanja Dacic;Beow Y. Yeap

  • Exon 19 Deletion Mutations of Epidermal Growth Factor Receptor Are Associated with Prolonged Survival in Non–Small Cell Lung Cancer Patients Treated with Gefitinib or Erlotinib

    David M. Jackman;Beow Y. Yeap;Lecia V. Sequist;Neal Lindeman

  • ALK Rearrangements Are Mutually Exclusive with Mutations in EGFR or KRAS: An Analysis of 1,683 Patients with Non–Small Cell Lung Cancer

    Justin F. Gainor;Anna M. Varghese;Sai-Hong Ignatius Ou;Sheheryar Kabraji

  • Impact of Epidermal Growth Factor Receptor and KRAS Mutations on Clinical Outcomes in Previously Untreated Non–Small Cell Lung Cancer Patients: Results of an Online Tumor Registry of Clinical Trials

    David M. Jackman;Vincent A. Miller;Leigh-Anne Cioffredi;Beow Y. Yeap

  • Allelic dilution obscures detection of a biologically significant resistance mutation in EGFR-amplified lung cancer

    Jeffrey A. Engelman;Toru Mukohara;Kreshnik Zejnullahu;Eugene Lifshits

  • Total Neoadjuvant Therapy With FOLFIRINOX Followed by Individualized Chemoradiotherapy for Borderline Resectable Pancreatic Adenocarcinoma: A Phase 2 Clinical Trial

    Janet E. Murphy;Jennifer Y. Wo;David P. Ryan;Wenqing Jiang

  • Multi-Institutional Phase II Study of High-Dose Hypofractionated Proton Beam Therapy in Patients With Localized, Unresectable Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma.

    Theodore S. Hong;Jennifer Y. Wo;Beow Y. Yeap;Edgar Ben-Josef

  • The Effect of Surgery and Grade on Outcome of Gastrointestinal Stromal Tumors

    Jean Pierre E N Pierie;Umar H Choudry;Alona Muzikansky;Beow Yong Yeap

  • Phase II Clinical Trial of Chemotherapy-Naïve Patients ≥ 70 Years of Age Treated With Erlotinib for Advanced Non–Small-Cell Lung Cancer

    David M. Jackman;Beow Y. Yeap;Neal I. Lindeman;Panos Fidias

  • Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer: A Phase 2 Clinical Trial.

    Janet E. Murphy;Jennifer Y. Wo;David P. Ryan;Jeffrey W. Clark

  • Differential Effects of Gefitinib and Cetuximab on Non–small-cell Lung Cancers Bearing Epidermal Growth Factor Receptor Mutations

    Toru Mukohara;Jeffrey A. Engelman;Nasser H. Hanna;Beow Y. Yeap

  • Clinical, pathologic, and biologic features associated with BRAF mutations in non-small cell lung cancer.

    Stephanie Cardarella;Atsuko Ogino;Mizuki Nishino;Mohit Butaney

  • Combined Vascular Endothelial Growth Factor Receptor and Epidermal Growth Factor Receptor (EGFR) Blockade Inhibits Tumor Growth in Xenograft Models of EGFR Inhibitor Resistance

    George N. Naumov;Monique B. Nilsson;Tina Cascone;Alexandra Briggs

  • Double unrelated reduced-intensity umbilical cord blood transplantation in adults

    Karen K. Ballen;Thomas R. Spitzer;Beow Y. Yeap;Steven McAfee

  • Differential induction of apoptosis in HER2 and EGFR addicted cancers following PI3K inhibition

    Anthony C. Faber;Danan Li;Young Chul Song;Mei-Chih Liang

  • Diabetes Impairs Hematopoietic Stem Cell Mobilization by Altering Niche Function

    Francesca Ferraro;Stefania Lymperi;Simón Méndez-Ferrer;Borja Saez

Frequent Co-Authors

Thomas F. DeLaney
Thomas F. DeLaney Harvard University
Alice T. Shaw
Alice T. Shaw Harvard University
David P. Ryan
David P. Ryan Harvard University
Nancy J. Tarbell
Nancy J. Tarbell Harvard University
Raphael Bueno
Raphael Bueno Brigham and Women's Hospital
Jeffrey W. Clark
Jeffrey W. Clark Harvard University
Andrew X. Zhu
Andrew X. Zhu Harvard University
David J. Sugarbaker
David J. Sugarbaker Baylor College of Medicine
William G. Richards
William G. Richards Brigham and Women's Hospital
Justin F. Gainor
Justin F. Gainor Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

While pursuing Medicine in the USA is a common route, there are numerous alternative healthcare careers and online degree options to consider. For those interested in direct patient care without a prior nursing background, online bsn programs for non nurses offer an accessible way to fast-track a Bachelor of Science in Nursing and start working in the field quickly.

If you prefer the business or administrative side of healthcare, exploring a accelerated healthcare administration degree program online could open doors to management and leadership roles within hospitals or clinics. Similarly, those looking for quick entry into the workforce can find promising prospects at the best online medical billing and coding schools, which train you for in-demand administrative positions.

For individuals drawn to practical nursing roles, attending an lpn school without teas test can streamline the admissions process and help you start your Licensed Practical Nurse (LPN) journey sooner. Each of these pathways enables you to contribute meaningfully to healthcare, often with more flexibility and faster completion times than traditional medical degrees.

Best Scientists Citing Beow Y. Yeap

Trending Scientists

Recently Published Articles